21 December 2017 Business Entertainment News

A HOLLYWOOD MOVIE ABOUT DIRTY PATENT SHENANIGANS

VSY Biotechnology is initiating a new movie project in order to raise awareness and explore supposed dirty patent shenanigans within the medical industry. 

 

VSY Biotechnology is initiating a new movie project in order to raise awareness and explore supposed dirty patent shenanigans within the medical industry. The Chairman of VSY Biotechnology Dr. Ercan Varlibas, who stated that they have started meeting with producers for this Hollywood movie, has already received 35 million dollars to support this project. Dr. Ercan Varlibas, who has worked with Jennifer Lopez previously, plans to contact the actress to discuss the project. 

Dr. Ercan Varlibas said ‘There are large companies with malicious intentions which want to establish monopolies over the market by hindering innovative developing companies via illegal methods. The simplest method employed by these unethical companies is to purchase a trivial patent and sue the targeted company by producing manipulative fake data. Even though these companies seem to be big, they are impotent and they fail to do research and develop new products’.

He also said that legal departments were partially to blame for this malpractice ‘These legal departments with a great budget transfer the funds to external lawyers who can use these funds to participate in all kinds of illegal activities to influence the courts; meanwhile, the legal departments are ostensibly innocent. The trinity between unethical companies, external lawyers, and patent courts has been present for years, and it keeps growing stronger in the present day. Someone has to put an end to this situation’.

However, Dr. Ercan Varlibas did make it clear that this is the case for a minority in the medical industry, legal profession and legal system.

The movie will be based around an established European company and will focus around the themes of patents in addition to exploring legal representation through to money trails within the sector.

21 December 2017